Non-NAFLD | NAFLD | P | |
---|---|---|---|
N | 336 | 108 | |
Age (years) | 86 (83–90) | 84 (82–88) | 0.006 |
BMI (kg/m2) | 23.6 ± 3.3 | 26.0 ± 3.0 | < 0.001 |
WC (cm) | 89 ± 9 | 97 ± 8 | < 0.001 |
SBP (mmHg) | 134 ± 21 | 136 ± 19 | 0.202 |
DBP (mmHg) | 69 ± 12 | 69 ± 12 | 0.986 |
Diabetes (%) | 36.9 | 41.5 | 0.394 |
Hypertension (%) | 79.8 | 94.4 | < 0.001 |
Current/ex-smoker (%) | 27.6 | 26.5 | 0.827 |
High education (%) | 80.0 | 86.5 | 0.135 |
Married status (%) | 92.7 | 90.6 | 0.481 |
Routine exercisea (%) | 41.3 | 44.2 | 0.599 |
MNA-SF score | 12.0 (10.0–13.3) | 13.0 (12.0–14.0) | < 0.001 |
Malnutrition/Nutritional Risk (%) | 36.3 | 13.2 | < 0.001 |
Lipid-lowering drug users (%) | 51.2 | 64.8 | 0.013 |
Antihypertensive drug users (%) | 61.3 | 75.9 | 0.006 |
TT (nmol/L) | 12.9 (8.5–18.4) | 9.5 (6.5–11.7) | < 0.001 |
E2 (pmol/L) | 140 (106–167) | 113 (83–136) | < 0.001 |
LH (IU/L) | 10.1 (6.8–21) | 9.5 (6.5–11.7) | 0.568 |
FSH (IU/L) | 17.8 (12.7–35.2) | 22.4 (14.2–42.9) | 0.025 |
HbA1c (%) | 5.7 (5.5–6.2) | 6.2 (5.8–6.8) | < 0.001 |
FPG (mmol/L) | 5.0 (4.7–5.6) | 5.6 (5.2–6.5) | < 0.001 |
FINS (mU/L) | 5.9 (4.0–9.4) | 11.0 (8.1–14.6) | < 0.001 |
TC (mmol/L) | 3.84 (3.22–4.64) | 4.01 (3.52–4.71) | 0.086 |
TG (mmol/L) | 0.90 (0.65–1.25) | 1.34 (1.05–2.08) | < 0.001 |
LDL-c (mmol/L) | 2.03 (1.64–2.72) | 2.33 (1.86–2.79) | 0.002 |
HDL-c (mmol/L) | 1.15 (0.94–1.40) | 0.96 (0.86–1.19) | < 0.001 |
ALT (U/L) | 12 (9–18) | 15 (11–20) | 0.004 |
AST (U/L) | 18 (15–22) | 19 (17–22) | 0.082 |
hsCRP (mg/L) | 1.34 (0.49–4.56) | 1.47 (0.81–2.72) | 0.555 |
PCT (ng/mL) | 0.036 (0.026–0.047) | 0.041 (0.029–0.054) | 0.007 |